Management tracks: Zai, Selecta

Zai Lab Ltd. (NASDAQ:ZLAB) hired Tao Fu as COO. Fu was EVP and chief commercial and business officer of Portola Pharmaceuticals Inc. (NASDAQ:PTLA) (see "Amid Launch Troubles, Portola Commercial Chief Fu Resigns").

Prior to Portola, he was VP and head of M&A and alliance management at Bristol-Myers Squibb Co. (NYSE:BMY), and was previously VP of business development at the Janssen unit of Johnson & Johnson (NYSE:JNJ), where he led global M&A activities. Fu has been a director at Zai since 2017...